Adelphi Group

adelphigroup.com

The Adelphi Group provides a wide range of strategic support services and consulting for global pharmaceutical clients. Adelphi is dedicated to the healthcare sector, providing services across strategic marketing, marketing and business intelligence, real-world observational research and disease-specific programmes, health and economic outcomes, market access, pricing and reimbursement, value insight, multi-channel health communications, scientific services, medical education, and strategic product

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BETTERLIFE SCALES UP MANUFACTURING OF AP-003 (INTERFERON ALPHA 2B) TO PREPARE FOR CLINICAL TRIALS

BetterLife Pharma Inc. | September 17, 2020

news image

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced it has entered into an agreement with List Biological Laboratories, Inc. (“List Labs”) for the manufacture of its proprietary interferon alpha 2b for the treatment of COVID-19. "Following our recent merger, we are proud to be continuing the development of Altum Pharmaceutical’s proprietary interferon alpha 2b inh...

Read More

MINIPCR BIO ANNOUNCES LAUNCH OF THE GELATO™ AN INTEGRATED DNA ANALYSIS SYSTEM

miniPCR bio | September 09, 2020

news image

miniPCR bio, a manufacturer of scientific tools for educators and researchers, today announced the launch of the GELATO™, an integrated DNA analysis system. GELATO™ combines gel electrophoresis with transillumination technology, allowing for simultaneous nucleic acid separation and visualization in a single, compact system. As a maker of innovative biotechnology for demanding settings, miniPCR bio has pioneered the development of tools that combine analytical power with the durabilit...

Read More

Cell and Gene Therapy

ILLUMINA UNVEILS REVOLUTIONARY NOVASEQ X SERIES TO RAPIDLY ACCELERATE GENOMIC DISCOVERIES AND IMPROVE HUMAN HEALTH

Illumina, Inc | September 30, 2022

news image

Illumina, Inc. a global leader in DNA sequencing and array-based technologies, announced the launch of the NovaSeq™ X Series new production-scale sequencers that will push the limits of what is possible with genomic medicine, enabling faster, more powerful, and more sustainable sequencing. Using revolutionary new technology, NovaSeq X Plus can generate more than 20,000 whole genomes per year – 2.5 times the throughput of prior sequencers – greatly accelerating genomic discovery...

Read More

Medical

STRAMSEN BIOTECH, INC. TO FUND NEXT PHASES OF CLINICAL TRIALS AND ADDITIONAL MEDICINE DISCOVERY RESEARCH

Stramsen Biotech, Inc | December 17, 2020

news image

Stramsen Biotech, Inc, a professional group of medication researchers from the Houston, Texas territory comprises of scientists who devote their lives each day to investigating and exploring both the cycles and logical instruments hidden the world we live in today. Colleagues have gotten a few honors and awards for research ventures, with a significant number of their activities and distributions accessible upon demand. Individuals incorporate PhD and University level professors who specialize i...

Read More
news image

BETTERLIFE SCALES UP MANUFACTURING OF AP-003 (INTERFERON ALPHA 2B) TO PREPARE FOR CLINICAL TRIALS

BetterLife Pharma Inc. | September 17, 2020

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced it has entered into an agreement with List Biological Laboratories, Inc. (“List Labs”) for the manufacture of its proprietary interferon alpha 2b for the treatment of COVID-19. "Following our recent merger, we are proud to be continuing the development of Altum Pharmaceutical’s proprietary interferon alpha 2b inh...

Read More
news image

MINIPCR BIO ANNOUNCES LAUNCH OF THE GELATO™ AN INTEGRATED DNA ANALYSIS SYSTEM

miniPCR bio | September 09, 2020

miniPCR bio, a manufacturer of scientific tools for educators and researchers, today announced the launch of the GELATO™, an integrated DNA analysis system. GELATO™ combines gel electrophoresis with transillumination technology, allowing for simultaneous nucleic acid separation and visualization in a single, compact system. As a maker of innovative biotechnology for demanding settings, miniPCR bio has pioneered the development of tools that combine analytical power with the durabilit...

Read More
news image

Cell and Gene Therapy

ILLUMINA UNVEILS REVOLUTIONARY NOVASEQ X SERIES TO RAPIDLY ACCELERATE GENOMIC DISCOVERIES AND IMPROVE HUMAN HEALTH

Illumina, Inc | September 30, 2022

Illumina, Inc. a global leader in DNA sequencing and array-based technologies, announced the launch of the NovaSeq™ X Series new production-scale sequencers that will push the limits of what is possible with genomic medicine, enabling faster, more powerful, and more sustainable sequencing. Using revolutionary new technology, NovaSeq X Plus can generate more than 20,000 whole genomes per year – 2.5 times the throughput of prior sequencers – greatly accelerating genomic discovery...

Read More
news image

Medical

STRAMSEN BIOTECH, INC. TO FUND NEXT PHASES OF CLINICAL TRIALS AND ADDITIONAL MEDICINE DISCOVERY RESEARCH

Stramsen Biotech, Inc | December 17, 2020

Stramsen Biotech, Inc, a professional group of medication researchers from the Houston, Texas territory comprises of scientists who devote their lives each day to investigating and exploring both the cycles and logical instruments hidden the world we live in today. Colleagues have gotten a few honors and awards for research ventures, with a significant number of their activities and distributions accessible upon demand. Individuals incorporate PhD and University level professors who specialize i...

Read More

Resources

resource image

Cell and Gene Therapy, Industrial Impact

Characterization and identification of glucuronide metabolites

Whitepaper

resource image

Industrial Impact

Bruker Services & Software

Video

resource image

Cell and Gene Therapy, Industrial Impact

Eliminate Noisy Oxygen Measurements in Bioreactors

Whitepaper

resource image

Cell and Gene Therapy, Industrial Impact

Characterization and identification of glucuronide metabolites

Whitepaper

resource image

Industrial Impact

Bruker Services & Software

Video

resource image

Cell and Gene Therapy, Industrial Impact

Eliminate Noisy Oxygen Measurements in Bioreactors

Whitepaper

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us